0000899243-22-037965.txt : 20221207
0000899243-22-037965.hdr.sgml : 20221207
20221207212603
ACCESSION NUMBER: 0000899243-22-037965
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221206
FILED AS OF DATE: 20221207
DATE AS OF CHANGE: 20221207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAAB THOMAS R II
CENTRAL INDEX KEY: 0001230708
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39473
FILM NUMBER: 221451311
MAIL ADDRESS:
STREET 1: C/O INSPIRE PHARMACEUTICALS, INC.
STREET 2: 4222 EMPEROR BLVD., SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LENSAR, Inc.
CENTRAL INDEX KEY: 0001320350
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 320125724
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2800 DISCOVERY DRIVE
STREET 2: SUITE 100
CITY: ORLANDO
STATE: FL
ZIP: 32826
BUSINESS PHONE: 888-536-7271
MAIL ADDRESS:
STREET 1: 2800 DISCOVERY DRIVE
STREET 2: SUITE 100
CITY: ORLANDO
STATE: FL
ZIP: 32826
FORMER COMPANY:
FORMER CONFORMED NAME: LensAR Inc
DATE OF NAME CHANGE: 20070703
FORMER COMPANY:
FORMER CONFORMED NAME: LaserSoft Vision Inc
DATE OF NAME CHANGE: 20050310
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-12-06
0
0001320350
LENSAR, Inc.
LNSR
0001230708
STAAB THOMAS R II
C/O LENSAR, INC.
2800 DISCOVERY DRIVE
ORLANDO
FL
32826
0
1
0
0
Chief Financial Officer
Common Stock
2022-12-06
4
P
0
2025
3.162
A
134404
D
Common Stock
2022-12-07
4
P
0
727
3.156
A
135131
D
The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.15 to $3.18. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
Includes (i) 970 shares acquired under the Issuer's Employee Stock Purchase Plan since January 13, 2022, the date of the last Form 4 filed by the Reporting Person (the "Reference Date"), and (ii) 19,276 shares that were previously awarded as restricted stock on July 22, 2020 (subject to an amendment of such award on December 7, 2020) and that vested between the Reference Date and the date hereof. Such restricted stock award was reported in the Reporting Person's Form 3 filed on September 17, 2020, and additional restricted stock awarded pursuant to the related amendment was reported in the Reporting Person's Form 4 filed on December 10, 2020.
The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.15 to $3.17. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
/s/ Thomas R. Staab, II
2022-12-07